Make 26% In 12 Months From A Cancer Play: This Co’s experimental cancer drug has shown promise in treating a cancer mutation known as KRAS G12C. Medicines targeting KRAS have the potential to be a $2 billion or more class of drugs. Read Full Strategy: http://bit.ly/2Liu8W4

